secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001654954-23-014239
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin Q1 FY2024 net loss narrows to $5.9M; Vyleesi revenue up 142% YoY
------------------------------------------------------------------------

- Net loss per share $(0.48) vs $(0.86) YoY; Vyleesi net revenue $2.1M, +142% YoY.
- Phase 3 DED study (PL9643) fully enrolled (n=570); topline data expected late Q4 2023.
- Phase 2 oral PL8177 in ulcerative colitis interim analysis targeted Q1 2024.
- Vyleesi gross sales $4.6M (+11% vs prior quarter); 7th consecutive quarter double-digit growth.
- Cash $5.5M at Sept 30; plus $4.5M net from October offering; expects cash into H1 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423014239/0001654954-23-014239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423014239/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-014239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer